Despite its promise, molecular oncology faces several challenges. One major issue is the heterogeneity of tumors, where different cells within a single tumor may have distinct genetic profiles. This complexity can make it difficult to identify appropriate targets for therapy. Additionally, the development of resistance to targeted therapies remains a significant hurdle, requiring ongoing research to overcome.
